John HATCHER

Person

Marlborough, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Azaindole inhibitors of wild-type and mutant forms of LRRK2
- Patent number 12,275,731
- Issue date Apr 15, 2025
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Degraders that target ALK and therapeutic uses thereof
- Patent number 12,233,128
- Issue date Feb 25, 2025
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic inhibitors of ALK, TRKA, TRKB, and ROS1
- Patent number 12,157,738
- Issue date Dec 3, 2024
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic inhibitors of DYRK1A
- Patent number 12,157,741
- Issue date Dec 3, 2024
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of EGFR and/or HER2 and methods of use
- Patent number 11,945,816
- Issue date Apr 2, 2024
- Dana-Farber Cancer Institute, Inc.
- John M. Hatcher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK...
- Patent number 11,858,897
- Issue date Jan 2, 2024
- Dana-Farber Cancer Institute, Inc.
- John Hatcher
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
IRAK degraders and uses thereof
- Patent number 11,542,251
- Issue date Jan 3, 2023
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of MALT1 and uses thereof
- Patent number 11,248,007
- Issue date Feb 15, 2022
- Cornell University
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of EGFR and/or HER2 and methods of use
- Patent number 11,186,574
- Issue date Nov 30, 2021
- Dana-Farber Cancer Institute, Inc.
- John M. Hatcher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK...
- Patent number 11,066,363
- Issue date Jul 20, 2021
- Dana-Farber Cancer Institute, Inc.
- John Hatcher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of interleukin-1 receptor-associated kinases and uses th...
- Patent number 10,975,055
- Issue date Apr 13, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
LRRK2 inhibitors and methods of making and using the same
- Patent number 10,913,744
- Issue date Feb 9, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MALT1 inhibitors and uses thereof
- Patent number 10,711,036
- Issue date Jul 14, 2020
- Cornell University
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for MALT1 degredation
- Patent number 10,689,366
- Issue date Jun 23, 2020
- Cornell University
- Ari M. Melnick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK...
- Patent number 10,508,082
- Issue date Dec 17, 2019
- Dana-Farber Cancer Institute, Inc.
- John Hatcher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
POTENT AND SELECTIVE INHIBITORS OF IRAK4
- Publication number 20240391899
- Publication date Nov 28, 2024
- Dana-Farber Cancer Institute, Inc.
- John M. Hatcher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL COMPOUNDS THAT DEGRADE ALK AND USES THEREOF
- Publication number 20240336643
- Publication date Oct 10, 2024
- Dana-Farber Cancer Institute, Inc.
- Baishan Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEGRADERS OF WILD-TYPE AND MUTANT FORMS OF LRRK2 AND USES THEREOF
- Publication number 20240308982
- Publication date Sep 19, 2024
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POTENT AND SELECTIVE IRREVERSIBLE INHIBITORS OF IRAK1
- Publication number 20240043405
- Publication date Feb 8, 2024
- Dana-Farber Cancer Institute, Inc.
- John M. Hatcher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIN-DEPENDENT KINASE INHIBITORS AND METHODS OF USE
- Publication number 20230365620
- Publication date Nov 16, 2023
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POTENT AND SELECTIVE COVALENT INHIBITORS OF SERINE-ARGININE PROTEIN...
- Publication number 20230331721
- Publication date Oct 19, 2023
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POTENT AND SELECTIVE INHIBITORS OF HER2
- Publication number 20230295167
- Publication date Sep 21, 2023
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POTENT AND SELECTIVE DEGRADERS OF ALK
- Publication number 20230158157
- Publication date May 25, 2023
- Dana-Farber Cancer Institute, Inc.
- John M. Hatcher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYANO-PYRIMIDINE INHIBITORS OF EGFR/HER2
- Publication number 20230137932
- Publication date May 4, 2023
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POTENT AND SELECTIVE AZAINDOLE INHIBITORS OF CDK8 AND CDK19
- Publication number 20230040191
- Publication date Feb 9, 2023
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEGRADERS THAT TARGET ALK AND THERAPEUTIC USES THEREOF
- Publication number 20220409731
- Publication date Dec 29, 2022
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIMIDINE INHIBITORS OF WILD-TYPE AND MUTANT FORMS OF LRRK2
- Publication number 20220204515
- Publication date Jun 30, 2022
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC INHIBITORS OF DYRK1A
- Publication number 20220112201
- Publication date Apr 14, 2022
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF EGFR AND/OR HER2 AND METHODS OF USE
- Publication number 20220106310
- Publication date Apr 7, 2022
- Dana-Farber Cancer Institute, Inc.
- John M. Hatcher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC INHIBITORS OF ALK, TRKA, TRKB, AND ROS1
- Publication number 20220033402
- Publication date Feb 3, 2022
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEGRADERS OF WILD-TYPE AND MUTANT FORMS OF LRRK2
- Publication number 20210361774
- Publication date Nov 25, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AZAINDOLE INHIBITORS OF WILD-TYPE AND MUTANT FORMS OF LRRK2
- Publication number 20210347772
- Publication date Nov 11, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 6,11-DIHYDRO-5H-BENZO[B]CARBAZOLES AS INHIBITORS OF ALK...
- Publication number 20210340102
- Publication date Nov 4, 2021
- Dana-Farber Cancer Institute, Inc.
- John Hatcher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IRAK DEGRADERS AND USES THEREOF
- Publication number 20210230144
- Publication date Jul 29, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME
- Publication number 20210115055
- Publication date Apr 22, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLIN-DEPENDENT KINASE DEGRADERS AND METHODS OF USE
- Publication number 20210054020
- Publication date Feb 25, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF MALT1 AND USES THEREOF
- Publication number 20200385405
- Publication date Dec 10, 2020
- Cornell University
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIN-DEPENDENT KINASE INHIBITORS AND METHODS OF USE
- Publication number 20200369715
- Publication date Nov 26, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND USES TH...
- Publication number 20200299257
- Publication date Sep 24, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
6,11-DIHYDRO-5H-BENZO[B]CARBAZOLE INHIBITORS OF ALK AND SRPK AND ME...
- Publication number 20200223798
- Publication date Jul 16, 2020
- Dana-Farber Cancer Institute, Inc.
- John HATCHER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITORS OF EGFR AND/OR HER2 AND METHODS OF USE
- Publication number 20200199121
- Publication date Jun 25, 2020
- Dana-Farber Cancer Institute, Inc.
- JOHN M. HATCHER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MALT1 INHIBITORS AND USES THEREOF
- Publication number 20190389904
- Publication date Dec 26, 2019
- Cornell University
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND USES TH...
- Publication number 20190276426
- Publication date Sep 12, 2019
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR MALT1 DEGRADATION
- Publication number 20190263785
- Publication date Aug 29, 2019
- Cornell University
- Ari M. Melnick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF ALK AND SRPK AND METHODS OF USE
- Publication number 20180258040
- Publication date Sep 13, 2018
- Dana-Farber Cancer Institute, Inc.
- John HATCHER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

John HATCHER

Person

Patents Grantslast 30 patents

Azaindole inhibitors of wild-type and mutant forms of LRRK2

Degraders that target ALK and therapeutic uses thereof

Macrocyclic inhibitors of ALK, TRKA, TRKB, and ROS1

Macrocyclic inhibitors of DYRK1A

Inhibitors of EGFR and/or HER2 and methods of use

Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK...

IRAK degraders and uses thereof

Inhibitors of MALT1 and uses thereof

Inhibitors of EGFR and/or HER2 and methods of use

Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK...

Inhibitors of interleukin-1 receptor-associated kinases and uses th...

LRRK2 inhibitors and methods of making and using the same

MALT1 inhibitors and uses thereof

Compounds for MALT1 degredation

Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK...

Patents Applicationslast 30 patents

POTENT AND SELECTIVE INHIBITORS OF IRAK4

BIFUNCTIONAL COMPOUNDS THAT DEGRADE ALK AND USES THEREOF

DEGRADERS OF WILD-TYPE AND MUTANT FORMS OF LRRK2 AND USES THEREOF

POTENT AND SELECTIVE IRREVERSIBLE INHIBITORS OF IRAK1

CYCLIN-DEPENDENT KINASE INHIBITORS AND METHODS OF USE

POTENT AND SELECTIVE COVALENT INHIBITORS OF SERINE-ARGININE PROTEIN...

POTENT AND SELECTIVE INHIBITORS OF HER2

POTENT AND SELECTIVE DEGRADERS OF ALK

CYANO-PYRIMIDINE INHIBITORS OF EGFR/HER2

POTENT AND SELECTIVE AZAINDOLE INHIBITORS OF CDK8 AND CDK19

DEGRADERS THAT TARGET ALK AND THERAPEUTIC USES THEREOF

PYRROLOPYRIMIDINE INHIBITORS OF WILD-TYPE AND MUTANT FORMS OF LRRK2

MACROCYCLIC INHIBITORS OF DYRK1A

INHIBITORS OF EGFR AND/OR HER2 AND METHODS OF USE

MACROCYCLIC INHIBITORS OF ALK, TRKA, TRKB, AND ROS1

DEGRADERS OF WILD-TYPE AND MUTANT FORMS OF LRRK2

AZAINDOLE INHIBITORS OF WILD-TYPE AND MUTANT FORMS OF LRRK2

SUBSTITUTED 6,11-DIHYDRO-5H-BENZO[B]CARBAZOLES AS INHIBITORS OF ALK...

IRAK DEGRADERS AND USES THEREOF

LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME

CYCLIN-DEPENDENT KINASE DEGRADERS AND METHODS OF USE

INHIBITORS OF MALT1 AND USES THEREOF

CYCLIN-DEPENDENT KINASE INHIBITORS AND METHODS OF USE

INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND USES TH...

6,11-DIHYDRO-5H-BENZO[B]CARBAZOLE INHIBITORS OF ALK AND SRPK AND ME...

INHIBITORS OF EGFR AND/OR HER2 AND METHODS OF USE

MALT1 INHIBITORS AND USES THEREOF

INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND USES TH...

COMPOUNDS FOR MALT1 DEGRADATION

INHIBITORS OF ALK AND SRPK AND METHODS OF USE